<DOC>
	<DOCNO>NCT02029885</DOCNO>
	<brief_summary>To demonstrate non-invasive renal denervation safe show net difference blood pressure reduction compare sham subject uncontrolled hypertension .</brief_summary>
	<brief_title>Sham Controlled Study Renal Denervation Subjects With Uncontrolled Hypertension</brief_title>
	<detailed_description>This study sham control , double blind study subject uncontrolled hypertension consist two arm , sham therapy . Bilateral renal denervation perform non-invasively use Kona Medical Surround Sound System delivers focus ultrasound therapy ablate nerve surround renal artery utilize real time ultrasound target tracking .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Subject least 18 year age 90 year age 2 . Average SBP ≥ 160 mmHg 3 . 24 hour average ABPM daytime SBP ≥ 135 mmHg . 4 . No medication change minimum 1 month prior screen . 5 . At minimum , subject must least three antihypertensive medication , one diuretic , must meet one follow full dose criterion : 1 . Highest label dose accord medication 's labeling ; 2 . Highest usual dose per clinical guideline JNC7 ; 3 . Highest tolerate dose ; and/or 4 . Highest appropriate dose subject per PI 's clinical judgment . 6 . Subject two function kidney . 7 . Subject eGFR value ≥ 30 ml/min/1.73 m² ( MDRD formula ) . 1 . Subject secondary cause hypertension 2 . Subject evidence clinically significant renal artery stenosis determine flow rate , velocity Doppler analysis ultrasound 3 . Subject kidney stone size location determine discretion investigator potentially interfere treatment 4 . Subject history intraabdominal surgery within past six month 5 . Subject heterogeneity kidney large cyst tumor determine discretion investigator potentially interfere treatment . 6 . Stenotic valvular heart disease BP reduction would hazardous determined refer physician . 7 . MI , unstable angina , CVA prior 6 month . 8 . Known severe primary pulmonary HTN 9 . Subject history myocardial infarction , unstable angina pectoris , cerebrovascular accident within last six month . 10 . Subject hemodynamically significant valvular heart disease . 11 . Subject BMI 40 km/m^2 12 . Subject target treatment depth 13 cm . 13 . Subject anatomy precludes treatment Kona Medical Surround Sound System . 14 . Subject pregnant , nursing , intend become pregnant trial period . 15 . Subject currently enrol potentially confound research . 16 . Subject condition , discretion investigator , would preclude participation trial . 17 . Subject unable , unwilling , comply protocolrequired followup schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Renal Denervation</keyword>
</DOC>